Skip to content
Bored Studies
RecruitingAccepts healthy volunteersPhase 1

Evaluate the Pharmacokinetics, Safety, and Tolerability of NSHO-101 in Healthy Participants

Ensho Therapeutics, Inc. · NCT07403552

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18+ · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Phase 1
Target enrollment
24
US sites recruiting
1
Study start
January 31, 2026
Record last updated
February 11, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The purpose of this study is to evaluate the pharmacokinetics, safety, and tolerability of NSHO-101 in Healthy Participants.

Being studied: NSHO-101

Conditions: Healthy

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Participants (males and females) at least 18 years of age
  • Ability to provide written informed consent
  • In good heath as determined by medical evaluation,
  • Willing and able to comply with trial restrictions, procedures, and requirements

Exclusion Criteria

  • Known sensitivity to any components of the IMP
  • History of relevant drug hypersensitivity
  • Presents or has a history of clinically significant diseases
  • History of difficulty swallowing tablets or capsules.
  • Any physical examination findings or medical history that might place the participant at an unacceptable risk for participation in this trial.

Recruiting US locations

Study contacts (from the official record)

  • Bittoo Kanwar, MD, MD · 973-314-8995 · operations@enshorx.com
All healthy volunteers studies in California →
Evaluate the Pharmacokinetics, Safety, and Tolerability of… (NCT07403552) | Bored Studies